The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 17, 2025

Filed:

Apr. 29, 2020
Applicant:

Ancestry.com Dna, Llc, Lehi, UT (US);

Inventors:

Catherine Ann Ball, Mountain View, CA (US);

Keith D. Noto, San Francisco, CA (US);

Kenneth G. Chahine, Park City, UT (US);

Mathew J. Barber, Chicago, IL (US);

Yong Wang, Foster City, CA (US);

Assignee:

Ancestry.com DNA, LLC, Lehi, UT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 20/20 (2019.01); G06F 17/18 (2006.01); G16B 5/00 (2019.01); G16B 5/20 (2019.01); G16B 20/00 (2019.01); G16B 40/00 (2019.01); G16B 40/20 (2019.01); G16B 40/30 (2019.01);
U.S. Cl.
CPC ...
G16B 20/20 (2019.02); G06F 17/18 (2013.01); G16B 5/00 (2019.02); G16B 5/20 (2019.02); G16B 20/00 (2019.02); G16B 40/00 (2019.02); G16B 40/20 (2019.02); G16B 40/30 (2019.02);
Abstract

Novel haplotype cluster Markov models are used to phase genomic samples. After the models are built, they rapidly and accurately phase new samples without requiring that the new samples be used to re-build the models. The models set transition probabilities such that the probability for an appearance of any allele within any haplotype is a non-zero number. Furthermore, the most unlikely pairs of haplotypes are discarded from each model at each level until ε of the likelihood mass at each level is discarded. The models are also constructed such that contributing windows of SNPs partially overlap so that phasing decisions near one of the extreme ends of any model is are not significantly determinative of the phase. Additionally, the models are configured such that two or more nodes can be merged during the building/updating procedure to consolidate haplotype clusters having similar distributions.


Find Patent Forward Citations

Loading…